ID UD15_HUMAN Reviewed; 534 AA. AC P35504; B8K294; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1994, sequence version 1. DT 27-MAR-2024, entry version 188. DE RecName: Full=UDP-glucuronosyltransferase 1A5 {ECO:0000303|PubMed:18004212}; DE Short=UGT1A5; DE EC=2.4.1.17 {ECO:0000269|PubMed:18674515}; DE AltName: Full=UDP-glucuronosyltransferase 1-5; DE Short=UDPGT 1-5; DE Short=UGT1*5; DE Short=UGT1-05; DE Short=UGT1.5; DE AltName: Full=UDP-glucuronosyltransferase 1-E; DE Short=UGT-1E; DE Short=UGT1E; DE Flags: Precursor; GN Name=UGT1A5 {ECO:0000312|HGNC:HGNC:12537}; Synonyms=GNT1, UGT1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=1339448; DOI=10.1016/s0021-9258(19)50724-4; RA Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., RA Owens I.S.; RT "A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP- RT glucuronosyltransferase isozymes with identical carboxyl termini."; RL J. Biol. Chem. 267:3257-3261(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=11434514; DOI=10.1097/00008571-200106000-00011; RA Gong Q.H., Cho J.W., Huang T., Potter C., Gholami N., Basu N.K., Kubota S., RA Carvalho S., Pennington M.W., Owens I.S., Popescu N.C.; RT "Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 RT gene complex locus."; RL Pharmacogenetics 11:357-368(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 98-534 (ISOFORM 2). RA Guillemette C., Levesque E., Girard H., Bernard O.; RL Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases. RN [5] RP FUNCTION (ISOFORM 2), ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY. RX PubMed=18004212; DOI=10.1097/fpc.0b013e3282f1f118; RA Girard H., Levesque E., Bellemare J., Journault K., Caillier B., RA Guillemette C.; RT "Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative RT splicing mechanism leading to nine additional UGT1A proteins that act as RT regulators of glucuronidation activity."; RL Pharmacogenet. Genomics 17:1077-1089(2007). RN [6] RP FUNCTION (ISOFORM 1), AND CATALYTIC ACTIVITY. RX PubMed=18674515; DOI=10.1016/j.bcp.2008.07.006; RA Alonen A., Finel M., Kostiainen R.; RT "The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards RT N2 in the tetrazole ring of losartan, candesartan, and zolarsartan."; RL Biochem. Pharmacol. 76:763-772(2008). CC -!- FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes CC phase II biotransformation reactions in which lipophilic substrates are CC conjugated with glucuronic acid to increase the metabolite's water CC solubility, thereby facilitating excretion into either the urine or CC bile (PubMed:18674515). Essential for the elimination and CC detoxification of drugs, xenobiotics and endogenous compounds CC (PubMed:18674515). Involved in the glucuronidation of the AGTR1 CC angiotensin receptor antagonist zolarsatan, a drug which can inhibit CC the effect of angiotensin II (PubMed:18674515). CC {ECO:0000269|PubMed:18674515}. CC -!- FUNCTION: [Isoform 2]: Lacks UGT glucuronidation activity but acts as a CC negative regulator of isoform 1. {ECO:0000269|PubMed:18004212}. CC -!- CATALYTIC ACTIVITY: CC Reaction=glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor CC beta-D-glucuronoside + H(+) + UDP; Xref=Rhea:RHEA:21032, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, CC ChEBI:CHEBI:132367, ChEBI:CHEBI:132368; EC=2.4.1.17; CC Evidence={ECO:0000269|PubMed:18674515}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21033; CC Evidence={ECO:0000305|PubMed:18674515}; CC -!- CATALYTIC ACTIVITY: CC Reaction=UDP-alpha-D-glucuronate + zolasartan = UDP + zolarsartan-1-N- CC beta-D-glucuronide; Xref=Rhea:RHEA:63744, ChEBI:CHEBI:58052, CC ChEBI:CHEBI:58223, ChEBI:CHEBI:149524, ChEBI:CHEBI:149527; CC Evidence={ECO:0000269|PubMed:18674515}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63745; CC Evidence={ECO:0000305|PubMed:18674515}; CC -!- SUBUNIT: Homodimer (By similarity). Homooligomer (By similarity). CC Interacts with UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9 CC and UGT1A10 to form heterodimers (By similarity). Isoform 1 interacts CC with isoform 2/i2 suggesting that oligomerization is involved in CC negative regulation of transferase activity by isoform 2. Isoform 1 CC also interacts with respective i2 isoforms of UGT1A1, UGT1A3, UGT1A4, CC UGT1A6, UGT1A7, UGT1A8, UGT1A9 and UGT1A10 (By similarity). CC {ECO:0000250|UniProtKB:P22309}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P22309}; Single-pass membrane protein CC {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=i1 {ECO:0000303|PubMed:18004212}; CC IsoId=P35504-1; Sequence=Displayed; CC Name=2; Synonyms=i2 {ECO:0000303|PubMed:18004212}, UGT1A5s; CC IsoId=P35504-2; Sequence=VSP_053961; CC -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in colon and CC small intestine. Neither isoform is expressed in liver, kidney or CC esophagus. {ECO:0000269|PubMed:18004212}. CC -!- MISCELLANEOUS: UGT1A5 isoform is part of the UGT1A complex locus which CC displays alternative use of promoters, first exons and terminal exons. CC The locus is defined by 13 first exons, which are alternatively spliced CC to 3 other common exons and 2 alternative terminal exons 5. From the 27 CC possible mRNA isoforms, 9 produce functionally active polypeptides CC (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7, 1A8, 1A9 and 1A10) called isoforms 1 CC (i1). Use of an alternative exon 5 (5b) as terminal exon is leading to CC 9 additional alternatively spliced products termed isoforms i2 and CC which lack transferase activity. {ECO:0000269|PubMed:18004212}. CC -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M84129; AAA61250.1; -; Genomic_DNA. DR EMBL; M84124; AAA61247.1; ALT_SEQ; Genomic_DNA. DR EMBL; M84122; AAA61247.1; JOINED; Genomic_DNA. DR EMBL; M84123; AAA61247.1; JOINED; Genomic_DNA. DR EMBL; AF297093; AAG30421.1; -; Genomic_DNA. DR EMBL; AC006985; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC114812; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; DQ383514; ABD42927.1; -; mRNA. DR CCDS; CCDS33404.1; -. [P35504-1] DR PIR; B42586; B42586. DR RefSeq; NP_061951.1; NM_019078.1. [P35504-1] DR AlphaFoldDB; P35504; -. DR SMR; P35504; -. DR BioGRID; 120057; 19. DR STRING; 9606.ENSP00000362513; -. DR ChEMBL; CHEMBL4523985; -. DR DrugCentral; P35504; -. DR CAZy; GT1; Glycosyltransferase Family 1. DR GlyConnect; 1877; 2 N-Linked glycans (1 site). DR GlyCosmos; P35504; 3 sites, 2 glycans. DR GlyGen; P35504; 3 sites, 2 N-linked glycans (1 site). DR iPTMnet; P35504; -. DR PhosphoSitePlus; P35504; -. DR BioMuta; UGT1A5; -. DR DMDM; 549153; -. DR jPOST; P35504; -. DR MassIVE; P35504; -. DR PaxDb; 9606-ENSP00000362513; -. DR PeptideAtlas; P35504; -. DR Antibodypedia; 47694; 29 antibodies from 14 providers. DR DNASU; 54579; -. DR Ensembl; ENST00000373414.4; ENSP00000362513.3; ENSG00000288705.1. [P35504-1] DR GeneID; 54579; -. DR KEGG; hsa:54579; -. DR MANE-Select; ENST00000373414.4; ENSP00000362513.3; NM_019078.2; NP_061951.1. DR AGR; HGNC:12537; -. DR CTD; 54579; -. DR DisGeNET; 54579; -. DR GeneCards; UGT1A5; -. DR HGNC; HGNC:12537; UGT1A5. DR HPA; ENSG00000288705; Tissue enhanced (gallbladder, intestine, liver). DR MalaCards; UGT1A5; -. DR MIM; 191740; gene. DR MIM; 606430; gene. DR neXtProt; NX_P35504; -. DR PharmGKB; PA37180; -. DR VEuPathDB; HostDB:ENSG00000240224; -. DR eggNOG; KOG1192; Eukaryota. DR GeneTree; ENSGT00940000162976; -. DR HOGENOM; CLU_012949_1_3_1; -. DR InParanoid; P35504; -. DR OMA; KYFCHIS; -. DR OrthoDB; 382054at2759; -. DR PhylomeDB; P35504; -. DR TreeFam; TF315472; -. DR BRENDA; 2.4.1.17; 2681. DR PathwayCommons; P35504; -. DR Reactome; R-HSA-156588; Glucuronidation. DR Reactome; R-HSA-9749641; Aspirin ADME. DR BioGRID-ORCS; 54579; 57 hits in 970 CRISPR screens. DR GeneWiki; UGT1A5; -. DR GenomeRNAi; 54579; -. DR Pharos; P35504; Tdark. DR PRO; PR:P35504; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; P35504; Protein. DR Genevisible; P35504; HS. DR GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0019899; F:enzyme binding; IBA:GO_Central. DR GO; GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0046982; F:protein heterodimerization activity; IEA:UniProt. DR GO; GO:0042803; F:protein homodimerization activity; IEA:UniProt. DR GO; GO:0052695; P:cellular glucuronidation; IBA:GO_Central. DR CDD; cd03784; GT1_Gtf-like; 1. DR Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2. DR InterPro; IPR002213; UDP_glucos_trans. DR InterPro; IPR035595; UDP_glycos_trans_CS. DR PANTHER; PTHR48043; EG:EG0003.4 PROTEIN-RELATED; 1. DR PANTHER; PTHR48043:SF157; UDP GLUCURONOSYLTRANSFERASE 1 FAMILY POLYPEPTIDE A3 PRECURSOR-RELATED; 1. DR Pfam; PF00201; UDPGT; 1. DR SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1. DR PROSITE; PS00375; UDPGT; 1. PE 1: Evidence at protein level; KW Alternative splicing; Endoplasmic reticulum; Glycoprotein; KW Glycosyltransferase; Membrane; Reference proteome; Signal; Transferase; KW Transmembrane; Transmembrane helix. FT SIGNAL 1..28 FT /evidence="ECO:0000255" FT CHAIN 29..534 FT /note="UDP-glucuronosyltransferase 1A5" FT /id="PRO_0000036004" FT TRANSMEM 492..508 FT /note="Helical" FT /evidence="ECO:0000255" FT CARBOHYD 119 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 296 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 348 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 436..534 FT /note="SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQY FT HSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH -> RKKQQSGR FT QM (in isoform 2)" FT /evidence="ECO:0000303|Ref.4" FT /id="VSP_053961" FT VARIANT 48 FT /note="L -> S (in dbSNP:rs3755323)" FT /id="VAR_052455" FT VARIANT 50 FT /note="D -> E (in dbSNP:rs3755322)" FT /id="VAR_059845" FT VARIANT 63 FT /note="L -> P (in dbSNP:rs3755321)" FT /id="VAR_052456" FT VARIANT 142 FT /note="H -> N (in dbSNP:rs3755320)" FT /id="VAR_059846" FT VARIANT 144 FT /note="T -> S (in dbSNP:rs28946885)" FT /id="VAR_052457" FT VARIANT 158 FT /note="A -> G (in dbSNP:rs12475068)" FT /id="VAR_052458" FT VARIANT 225 FT /note="H -> Y (in dbSNP:rs17862867)" FT /id="VAR_052459" FT VARIANT 249 FT /note="V -> L (in dbSNP:rs17862868)" FT /id="VAR_052460" FT VARIANT 259 FT /note="G -> R (in dbSNP:rs3892170)" FT /id="VAR_052461" SQ SEQUENCE 534 AA; 60071 MW; 05989F2A18EEFAA4 CRC64; MATGLQVPLP QLATGLLLLL SVQPWAESGK VLVVPTDGSH WLSMREALRD LHARGHQVVV LTLEVNMYIK EENFFTLTTY AISWTQDEFD RLLLGHTQSF FETEHLLMKF SRRMAIMNNM SLIIHRSCVE LLHNEALIRH LHATSFDVVL TDPFHLCAAV LAKYLSIPAV FFLRNIPCDL DFKGTQCPNP SSYIPRLLTT NSDHMTFLQR VKNMLYPLAL SYLCHAVSAP YASLASELFQ REVSVVDLVS HASVWLFRGD FVMDYPRPIM PNMVFIGGIN CANGKPLSQE FEAYINASGE HGIVVFSLGS MVSEIPEKKA MAIADALGKI PQTVLWRYTG TRPSNLANNT ILVKWLPQND LLGHPMTRAF ITHAGSHGVY ESICNGVPMV MMPLFGDQMD NAKRMETKGA GVTLNVLEMT SEDLENALKA VINDKSYKEN IMRLSSLHKD RPVEPLDLAV FWVEFVMRHK GAPHLRPAAH DLTWYQYHSL DVIGFLLAVV LTVAFITFKC CAYGYRKCLG KKGRVKKAHK SKTH //